Cargando…
HDV+HBV hepatitis reactivation due to immunossuppressive therapy for hematological malignancies – an increasingly complex challenge
Autores principales: | Molagic, Violeta, Mihăilescu, Raluca, Popescu, Cristina, Tilişcan, Cătălin, Rădulescu, Mihaela, Năstase, Raluca, Moroti, Ruxandra, Poghirc, Viorica, Aramă, Victoria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3882657/ http://dx.doi.org/10.1186/1471-2334-13-S1-O24 |
Ejemplares similares
-
Tuberculosis reactivation during novel, biologic therapy
por: Popescu, Cristina, et al.
Publicado: (2013) -
Treatment of chronic HBV hepatitis – between immune control and virological control
por: Popescu, Cristina, et al.
Publicado: (2014) -
HBV reactivation under immunosuppressive treatment – a case series
por: Rădulescu, Mihaela, et al.
Publicado: (2014) -
Clinical and epidemiologic features of community versus hospital-acquired Clostridium difficile infection
por: Molagic, Violeta, et al.
Publicado: (2014) -
Inflammatory patterns in patients with chronic hepatitis C
por: Ion, Daniela Adriana, et al.
Publicado: (2013)